Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:

Press releases

February 22, 2022

Immunovia invited to the 42nd Annual Cowen Health Care Conference

Read press release
February 17, 2022 | REGULATORY

Immunovia Publishes Full Year Report 2021

Read press release
February 17, 2022

IMMray™ PanCan-d – peer-reviewed, blinded validation study now published in Clinical and Translational Gastroenterology

Read press release
February 4, 2022

Invitation to Immunovia’s Q4 presentation

Read press release
February 3, 2022 | REGULATORY

Immunovia postpones Annual General Meeting pending the Temporary Meetings Act

Read press release
January 20, 2022 | REGULATORY

Immunovia appoints Philipp Mathieu as Acting CEO

Read press release
November 30, 2021 | REGULATORY

Immunovia’s CEO to step down during 2022

Read press release
November 26, 2021

Immunovia appoints new Senior Director Investor Relations and Corporate Communications

Read press release
November 23, 2021

Immunovia Honored World Pancreatic Cancer Day by a Grand Opening Celebration of the US Subsidiary Immunovia, Inc.

Read press release
November 11, 2021 | REGULATORY

Immunovia Publishes Report for the Third Quarter 2021

Read press release
November 5, 2021

Immunovia to Present at Jefferies London Healthcare Conference

Read press release
October 29, 2021

Immunovia, Inc.’s Medical Director Dr. Thomas King Invited as Keynote Speaker by US National Cancer Institute

Read press release
1 5 6 7 8 9 27